Literature DB >> 24574750

Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.

Ming Bai1, Chuang-Ye He1, Xing-Shun Qi1, Zhan-Xin Yin1, Jian-Hong Wang1, Wen-Gang Guo1, Jing Niu1, Jie-Lai Xia1, Zhuo-Li Zhang1, Andrew C Larson1, Kai-Chun Wu1, Dai-Ming Fan1, Guo-Hong Han1.   

Abstract

AIM: To evaluate the effect of the shunting branch of the portal vein (PV) (left or right) and the initial stent position (optimal or suboptimal) of a transjugular intrahepatic portosystemic shunt (TIPS).
METHODS: We retrospectively reviewed 307 consecutive cirrhotic patients who underwent TIPS placement for variceal bleeding from March 2001 to July 2010 at our center. The left PV was used in 221 patients and the right PV in the remaining 86 patients. And, 224 and 83 patients have optimal stent position and sub-optimal stent positions, respectively. The patients were followed until October 2011 or their death. Hepatic encephalopathy, shunt dysfunction, and survival were evaluated as outcomes. The difference between the groups was compared by Kaplan-Meier analysis. A Cox regression model was employed to evaluate the predictors.
RESULTS: Among the patients who underwent TIPS to the left PV, the risk of hepatic encephalopathy (P = 0.002) and mortality were lower (P < 0.001) compared to those to the right PV. Patients who underwent TIPS with optimal initial stent position had a higher primary patency (P < 0.001) and better survival (P = 0.006) than those with suboptimal initial stent position. The shunting branch of the portal vein and the initial stent position were independent predictors of hepatic encephalopathy and shunt dysfunction after TIPS, respectively. And, both were independent predictors of survival.
CONCLUSION: TIPS placed to the left portal vein with optimal stent position may reduce the risk of hepatic encephalopathy and improve the primary patency rates, thereby prolonging survival.

Entities:  

Keywords:  Cirrhosis; Portal vein; Stent position; Transjugular intrahepatic portosystemic shunt; Variceal bleeding

Mesh:

Year:  2014        PMID: 24574750      PMCID: PMC3921486          DOI: 10.3748/wjg.v20.i3.774

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration.

Authors:  M Plauth; A E Roske; P Romaniuk; E Roth; R Ziebig; H Lochs
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.

Authors:  G Pomier-Layrargues; J P Villeneuve; M Deschênes; B Bui; P Perreault; D Fenyves; B Willems; D Marleau; M Bilodeau; M Lafortune; M P Dufresne
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

Review 3.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

4.  Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis.

Authors:  Zhiping Yang; Guohong Han; Qiong Wu; Xiaofei Ye; Zhichao Jin; Zhanxin Yin; Xingshun Qi; Ming Bai; Kaichun Wu; Daiming Fan
Journal:  J Gastroenterol Hepatol       Date:  2010-11       Impact factor: 4.029

5.  Early use of TIPS in patients with cirrhosis and variceal bleeding.

Authors:  Juan Carlos García-Pagán; Karel Caca; Christophe Bureau; Wim Laleman; Beate Appenrodt; Angelo Luca; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Joachim Mössner; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

6.  Follow-up study of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.

Authors:  Hui Xue; Jia Yuan; Ying Chao-Li; Muna Palikhe; Jia Wang; Liang Shan-Lv; Wen Qiao
Journal:  Dig Dis Sci       Date:  2011-06-04       Impact factor: 3.199

7.  Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.

Authors:  Guohong Han; Xingshun Qi; Chuangye He; Zhanxin Yin; Jianhong Wang; Jielai Xia; Zhiping Yang; Ming Bai; Xiangjie Meng; Jing Niu; Kaichun Wu; Daiming Fan
Journal:  J Hepatol       Date:  2010-08-27       Impact factor: 25.083

8.  How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts.

Authors:  M Rössle; V Siegerstetter; M Olschewski; A Ochs; E Berger; K Haag
Journal:  Am J Gastroenterol       Date:  2001-12       Impact factor: 10.864

9.  Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial.

Authors:  Lei Chen; Tianli Xiao; Wensheng Chen; Qingling Long; Rongjun Li; Dianchun Fang; Rongquan Wang
Journal:  Liver Int       Date:  2009-04-06       Impact factor: 5.828

10.  Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.

Authors:  Oliviero Riggio; Stefania Angeloni; Filippo Maria Salvatori; Adriano De Santis; Federica Cerini; Alessio Farcomeni; Adolfo Francesco Attili; Manuela Merli
Journal:  Am J Gastroenterol       Date:  2008-09-04       Impact factor: 10.864

View more
  13 in total

1.  Combined Y-configured stents for revising occluded transjugular intrahepatic portosystemic shunt.

Authors:  Xiaoze Wang; Yongjun Zhu; Ming Zhu; Xuefeng Luo; Li Yang
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

2.  Transjugular intrahepatic portosystemic shunt combined with esophagogastric variceal embolization in the treatment of a large gastrorenal shunt.

Authors:  Qin Jiang; Ming-Quan Wang; Guo-Bing Zhang; Qiong Wu; Jian-Ming Xu; De-Run Kong
Journal:  World J Hepatol       Date:  2016-07-18

3.  Impact of PTFE-covered stent position and extension on TIPS patency.

Authors:  Joshua K Cho; Juan Serna; Timothy W I Clark; Mandeep Dagli; Jeffrey I Mondschein; Richard D Shlansky-Goldberg; Scott O Trerotola; Michael C Soulen; S William Stavropoulos; Gregory J Nadolski
Journal:  Abdom Radiol (NY)       Date:  2020-11

4.  The Effect of Puncture Sites of Portal Vein in TIPS with ePTFE-Covered Stents on Postoperative Long-Term Clinical Efficacy.

Authors:  Si-Liang Chen; Peng Hu; Zhi-Peng Lin; Jian-Bo Zhao
Journal:  Gastroenterol Res Pract       Date:  2019-01-09       Impact factor: 2.260

5.  Transjugular intrahepatic portosystemic shunt placement: portal vein puncture guided by 3D/2D image registration of contrast-enhanced multi-detector computed tomography and fluoroscopy.

Authors:  Timo C Meine; Cornelia L A Dewald; L S Becker; Aline Mähringer-Kunz; Benjamin Massoumy; Sabine K Maschke; Martha M Kirstein; Thomas Werncke; Frank K Wacker; Bernhard C Meyer; Jan B Hinrichs
Journal:  Abdom Radiol (NY)       Date:  2020-11

6.  Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome.

Authors:  Hongwei Zhao; Fuquan Liu; Zhendong Yue; Lei Wang; Zhenhua Fan; Fuliang He
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

7.  Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt.

Authors:  Shi-Hua Luo; Jian-Guo Chu; He Huang; Ke-Chun Yao
Journal:  World J Gastroenterol       Date:  2017-07-14       Impact factor: 5.742

8.  Use of concomitant variceal embolization and prophylactic antiplatelet/anticoagulative in transjugular intrahepatic portosystemic shunting: A retrospective study of 182 cirrhotic portal hypertension patients.

Authors:  Yingmei Tang; Sheng Zheng; Jinhui Yang; Weimin Bao; Lihong Yang; Yingchun Li; Ying Xu; Jing Yang; Yuyun Tong; Jinhang Gao; Chengwei Tang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids.

Authors:  Shihua Luo; Jianguo Chu; He Huang; Kechun Yao
Journal:  Biomed Res Int       Date:  2018-06-13       Impact factor: 3.411

Review 10.  Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.

Authors:  Sasidharan Rajesh; Tom George; Cyriac Abby Philips; Rizwan Ahamed; Sandeep Kumbar; Narain Mohan; Meera Mohanan; Philip Augustine
Journal:  World J Gastroenterol       Date:  2020-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.